NCT00177021View on ClinicalTrials.gov

Aldara for the Treatment of Extensive Alopecia Areata

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

August 31, 2002

Conditions
Alopecia Areata
Interventions
DRUG

Aldara Cream 5%

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

National Alopecia Areata Foundation

OTHER

collaborator

3M

INDUSTRY

lead

Hordinsky, Maria K., MD

INDIV

NCT00177021 - Aldara for the Treatment of Extensive Alopecia Areata | Biotech Hunter | Biotech Hunter